[Application of panthesin-hydergin preparation (PH 203) in the treatment of thrombophlebitis & pulmonary infarct].
D062365:Aminobenzoates / Q000627:therapeutic use*; D004088:Dihydroergotoxine; D004338:Drug Combinations; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D007238:Infarction; D007930:Leucine / Q000031:analogs & derivatives; D008168:Lung; D011343:Procaine / Q000031:analogs & derivatives; D013924:Thrombophlebitis / Q000628:therapy*; D062366:para-Aminobenzoates
D062365:Aminobenzoates; D004338:Drug Combinations; D004876:Ergot Alkaloids; C006783:dihydroergotoxin, p-aminobenzoyl-N-diethyl-leucinol drug combination; D062366:para-Aminobenzoates; D004088:Dihydroergotoxine; D011343:Procaine; C005426:leucinocaine mesylate; D007930:Leucine
AMINOBENZOATES/therapeutic use; ERGOT ALKALOIDS/therapeutic use; LUNGS/infarction; THROMBOPHLEBITIS/therapy
O stosowaniu pantezynyhyderginy (PH 203) w leczeniu zakrzepowego zapalenia zyłl oraz zawałlów płluc.